Evolocumab — Nutrient Associations & Health Patterns
Also known as: Evolocumab (Repatha)
Drug Class: PCSK9 inhibitor
Evolocumab is a PCSK9 inhibitor that may affect nutrient status or medication timing in some contexts. WePattern Pattern Health Intelligence maps evidence-qualified nutrient associations, side effects, and interaction context linked to Evolocumab.
Reported Nutrient Associations for Evolocumab
Peer-reviewed research reports relationships involving the following nutrients. WePattern surfaces them as evidence-qualified associations; they do not establish deficiency, causation, or a fixed timeline for an individual.
- Vitamin E
- CoQ10
Common Side Effects of Evolocumab
- Injection site reactions
- Upper respiratory infections
- Flu-like symptoms
- Muscle pain
- Fatigue
- Back pain
Key Drug Interactions — Evolocumab
Evolocumab has 2 documented drug-drug interactions in WePattern's Pattern Health Intelligence database. Key interactions include:
- Statins (often used together)
- Other lipid-lowering therapies
Frequently Asked Questions
What nutrient associations are reported for Evolocumab?
Evolocumab has reported nutrient associations involving Vitamin E, CoQ10 in clinical research. This does not establish that every person will become deficient or that the medication caused an individual result.
Which nutrient relationships are mapped for Evolocumab?
WePattern maps reported associations involving: Vitamin E, CoQ10. The strength, mechanism, dose, duration, and clinical relevance vary, so a clinician or pharmacist should interpret them in context.
What are the side effects of Evolocumab?
Common side effects associated with Evolocumab include: Injection site reactions; Upper respiratory infections; Flu-like symptoms; Muscle pain; Fatigue.